Form 4: Astera Labs Director Jack R. Lazar Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director Jack R. Lazar of Astera Labs, Inc. sold common stock in multiple transactions on February 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 18, 2025, Jack R. Lazar, a director of Astera Labs, Inc., sold shares of common stock.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 22, 2024.
- The transactions involved multiple sales at varying prices.
- Following the reported transactions, Lazar still beneficially owns 117,500 shares of Astera Labs common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to set up 10b5-1 trading plans to sell shares over time to avoid accusations of trading on material non-public information.
Stakeholder Impact
- The stock sale could have a minor negative impact on shareholder sentiment, although it is likely to be minimal given the pre-planned nature of the transactions.
Key Dates
| Date | Description |
|---|---|
| 2024/05/22 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| 2025/02/18 | Date of the stock sale transactions |
| 2025/02/20 | Date of the Form 4 filing |
Keywords
Astera Labs, ALAB, Jack R. Lazar, Form 4, insider trading, Rule 10b5-1, stock sale, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.